Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,288 total articles
Twist Bioscience Corp (NASDAQ:TWST) CFO Adam Laponis completed a non-discretionary sale of 2,399 shares on July 9, 2026, generating $226,307 to fulfill tax withholding duties tied to Restricted Stock Unit vesting. The transaction occurs amid a 9.3% weekly stock decline and heightened market volatility, even as analyst firms highlight the company’s …
HRT Financial LP, recognized as a 10% owner of Bluejay Diagnostics, Inc. (NASDAQ:BJDX), disclosed a combination of purchase and sale activity for the company's common stock. The firm sold shares valued at $48,913 while simultaneously acquiring stock worth $96,710. These transactions take place against a backdrop of recent corporate developments, in…
HRT Financial LP has increased its position in Shuttle Pharmaceuticals Holdings, Inc. through recent share purchases. The acquisition occurs as Shuttle Pharmaceuticals navigates significant corporate changes, including a completed merger and an approved reverse stock split. The company's stock has experienced substantial declines over recent period…
QNB Corp. director Joseph W Major recently increased his stake in the company through a targeted purchase of common stock, according to regulatory filings. The transaction underscores continued executive confidence as the financial institution advances its operational integration and maintains a long-standing dividend record. This activity occurs w…
Azar Samak L, the Chief Legal Officer at GLOBALFOUNDRIES Inc. (NASDAQ:GFS), recently executed a sale of 335 ordinary shares on July 9, 2026, generating proceeds of $23,751. The transaction, conducted at a price of $70.90 per share, was carried out under a Rule 10b5-1 trading plan previously established by the executive. Following this sale, Samak L…
Atlas Infrastructure Partners (UK) Ltd. executed a strategic acquisition of H2O America (NASDAQ:HTO) shares on July 7, 2026, reinforcing its position as a significant shareholder. This transaction occurs against a backdrop of mixed Q1 2026 financial performance for HTO, where earnings and revenue fell short of analyst expectations, yet market react…
Horizon Kinetics Asset Management LLC has increased its direct holding in Texas Pacific Land Corp (NYSE: TPL) through a recent purchase, while the energy and land management company reported first-quarter 2026 financial results that exceeded analyst expectations. The acquisition occurs alongside a strategic agreement with Chevron for Project Kilby …
Horizon Kinetics Asset Management LLC, which serves as the investment adviser to RENN Fund, Inc., executed a recent acquisition of the fund's common stock. The transaction, valued at $2,283, involved the purchase of 756 shares on July 10, 2026, bringing the firm's total direct holding to 933,420 shares. As a significant 10% owner, Horizon Kinetics …
Peter R. Matt, President and CEO of Commercial Metals Co (NYSE:CMC), increased his direct ownership stake through a recent equity purchase. The transaction occurred alongside the company reporting fiscal third-quarter 2026 financial metrics that surpassed consensus estimates. While management activity and earnings strength suggest internal confiden…
Jorey Chernett, a significant 10% shareholder in The Oncology Institute, Inc. (NASDAQ: TOI), executed a direct purchase of 15,000 shares on July 10, 2026, valued at $87,750. This transaction brings Chernett's total holding to 10,630,858 shares. The insider buying activity occurs as TOI trades near its 52-week high of $6.11, supported by recent corp…
Saba Capital Management, L.P. has executed a significant divestment from BlackRock ESG Capital Allocation Term Trust (NASDAQ:ECAT), selling common shares valued at approximately $2.08 million. The transactions occurred over two consecutive days in July 2026, reflecting a strategic reduction in a trust that currently offers a substantial dividend yi…
Coastlands Capital LP, a significant 10% shareholder in ADIAL PHARMACEUTICALS, INC. (NASDAQ:ADIL), has increased its stake through recent open-market purchases. This activity coincides with broader corporate developments, including a private placement financing event and strategic asset acquisitions that aim to expand the company's therapeutic pipe…
Mahesh Choudhury, Principal Financial Officer of ConnectM Technology Solutions, Inc. (NASDAQ:CNTM), has acquired 3,622 shares of the company's common stock over a five-day period. The purchases, totaling approximately $31,766, occurred between June 22, 2026, and June 26, 2026. Choudhury's transactions took place while the stock was declining, with …
Anixa Biosciences CEO Amit Kumar acquired 5,000 shares at $3.04 per share on July 10, 2026, increasing his direct holdings to 635,812 shares. The transaction coincides with the company's clinical trial milestones and the grant of a South Korean patent for its breast cancer vaccine technology. Despite recent progress, the company reported a net loss…
IperionX Ltd (NASDAQ:IPX) Chief Executive Officer Anastasios Arima executed a significant personal equity purchase, acquiring 138,720 ordinary shares valued at approximately $497,227 on July 10, 2026. This transaction occurs against a backdrop of recent corporate financing activities and analyst coverage, signaling continued strategic alignment bet…
Todd Hannigan, serving as Executive Chairman of IperionX Ltd (NASDAQ:IPX), has significantly increased his direct ownership in the company through recent share acquisitions. This activity occurs against a backdrop of substantial stock price declines over the past six months, despite ongoing analyst optimism and a recent public offering. The transac…
An entity connected to SharkNinja, Inc. director Wang Xuning has completed a substantial sale of company shares, raising over $400 million. The transaction occurs as the household appliance manufacturer's stock approaches its highest point in the past year, coinciding with recent analyst upgrades and the introduction of a new premium hair styling d…
Jon Halbert, a director at Caris Life Sciences, Inc. (NASDAQ: CAI), has executed a significant insider purchase, acquiring 68,000 shares of the company's common stock on May 15, 2026. The transaction, valued at $990,080, was facilitated through LAH Investments, Ltd., and reflects a weighted average purchase price of $14.56 per share. This acquisiti…
Gregory A. Sandfort, a director at Genesco Inc. (NYSE:GCO), has increased his stake in the company through a recent purchase of 2,958 shares. The transaction, executed on July 9, 2026, valued at $33.80 per share, totals $99,980. This acquisition price matches InvestingPro’s Fair Value for the stock, suggesting the director views the current valuati…
Mark H. Rachesky, a ten percent owner and director at Lionsgate Studios Corp. (NASDAQ: LION), has executed a substantial series of indirect share transfers through a continuation fund transaction, according to an SEC Form 4 filing dated July 8, 2026. The restructuring involved the movement of over 85 million shares across multiple affiliated entiti…
Mina Rezk, the Chief Technology Officer and director at Aeva Technologies, Inc. (NASDAQ: AEVA), executed a non-discretionary sale of 64,821 shares on July 8, 2026. The transaction, valued at $1,371,897, was triggered by the vesting of time-based restricted stock units and was specifically designated to satisfy tax withholding obligations. This auto…
Saurabh Sinha, serving as the Chief Financial Officer for Aeva Technologies, Inc., executed a sale of 20,620 shares of the company's common stock on July 8, 2026. This transaction, valued at approximately $436,409, involved shares sold at $21.1644 each. The sale was classified as a non-discretionary transaction, specifically intended to cover tax w…
Aeva Technologies Inc. (NASDAQ: AEVA) Chief Executive Officer Soroush Salehian Dardashti executed a sale of 64,821 common shares on July 8, 2026, generating approximately $1,371,897. The transaction occurred at a per-share price of $21.1644 and was classified as an automatic, non-discretionary sale intended to cover tax withholding requirements ass…
Eliyahou Harari, a significant shareholder holding a 10% stake in CapsoVision, Inc. (CV), executed a substantial equity purchase on July 8, 2026, according to Securities and Exchange Commission filings. The transaction involved the acquisition of 81,300 shares at $6.09 per share, totaling $495,117. This purchase price exceeds the stock's prevailing…
Apogee Therapeutics CEO Michael Henderson sold 20,000 shares worth $2.67 million on July 8, 2026, under a pre-existing trading plan. The transaction coincides with the company's pending acquisition by AbbVie for $135.11 per share in cash, valuing Apogee at approximately $10.9 billion. Following the acquisition announcement, several analysts have ad…
